BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11518039)

  • 1. Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity.
    Peltomaa R; Paimela L; Harvey S; Helve T; Leirisalo-Repo M
    Rheumatol Int; 2001 Jul; 20(5):192-6. PubMed ID: 11518039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis.
    Harvey S; Whaley J; Eberhardt K
    Scand J Rheumatol; 2000; 29(6):391-3. PubMed ID: 11132209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters.
    Matsumoto T; Tsurumoto T
    Clin Exp Rheumatol; 2001; 19(6):655-60. PubMed ID: 11791636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction.
    Johansen JS; Kirwan JR; Price PA; Sharif M
    Scand J Rheumatol; 2001; 30(5):297-304. PubMed ID: 11727845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.
    Johansen JS; Stoltenberg M; Hansen M; Florescu A; Hørslev-Petersen K; Lorenzen I; Price PA
    Rheumatology (Oxford); 1999 Jul; 38(7):618-26. PubMed ID: 10461474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
    Syversen SW; Goll GL; van der Heijde D; Landewé R; Gaarder PI; Odegård S; Haavardsholm EA; Kvien TK
    J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.
    Brahe CH; Dehlendorff C; Østergaard M; Johansen JS; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard H; Hansen I; Lottenburger T; Jacobsen S; Jurik AG; Hetland ML
    Scand J Rheumatol; 2018 Jul; 47(4):259-269. PubMed ID: 29336711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome.
    Knudsen LS; Klarlund M; Skjødt H; Jensen T; Ostergaard M; Jensen KE; Hansen MS; Hetland ML; Nielsen HJ; Johansen JS
    J Rheumatol; 2008 Jul; 35(7):1277-87. PubMed ID: 18597410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.
    Conrozier T; Carlier MC; Mathieu P; Colson F; Debard AL; Richard S; Favret H; Bienvenu J; Vignon E
    Ann Rheum Dis; 2000 Oct; 59(10):828-31. PubMed ID: 11005786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.
    Volck B; Johansen JS; Stoltenberg M; Garbarsch C; Price PA; Ostergaard M; Ostergaard K; Løvgreen-Nielsen P; Sonne-Holm S; Lorenzen I
    Osteoarthritis Cartilage; 2001 Apr; 9(3):203-14. PubMed ID: 11300743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.
    Vos K; Steenbakkers P; Miltenburg AM; Bos E; van Den Heuvel MW; van Hogezand RA; de Vries RR; Breedveld FC; Boots AM
    Ann Rheum Dis; 2000 Jul; 59(7):544-8. PubMed ID: 10873965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observations on the increased serum levels of YKL-40 in patients with rheumatoid arthritis and osteoarthritis].
    Morgante M; Metelli MR; Morgante D
    Minerva Med; 2001 Jun; 92(3):151-3. PubMed ID: 11404723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis.
    Kazakova M; Batalov A; Deneva T; Mateva N; Kolarov Z; Sarafian V
    Rheumatol Int; 2013 Feb; 33(2):341-6. PubMed ID: 22451025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [YKL 40: marker of disease activity in rheumatoid arthritis?].
    Morgante M; Di Munno O; Morgante D
    Minerva Med; 1999; 90(11-12):437-41. PubMed ID: 10829806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease.
    La Montagna G; D'Angelo S; Valentini G
    J Rheumatol; 2003 Oct; 30(10):2147-51. PubMed ID: 14528508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate.
    Knudsen LS; Ostergaard M; Baslund B; Narvestad E; Petersen J; Nielsen HJ; Ejbjerg BJ; Szkudlarek M; Johansen JS
    Scand J Rheumatol; 2006; 35(6):489-91. PubMed ID: 17343261
    [No Abstract]   [Full Text] [Related]  

  • 17. YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?
    Kazakova MH; Batalov AZ; Mateva NG; Kolarov ZG; Sarafian VS
    Folia Med (Plovdiv); 2017 Mar; 59(1):37-42. PubMed ID: 28384116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum levels of YKL-40 in patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Dimoulios P; Vardas E; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
    Int J Colorectal Dis; 2003 May; 18(3):254-9. PubMed ID: 12673492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
    Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
    J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis.
    Sekine T; Masuko-Hongo K; Matsui T; Asahara H; Takigawa M; Nishioka K; Kato T
    Ann Rheum Dis; 2001 Jan; 60(1):49-54. PubMed ID: 11114282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.